Monday, May 4, 2009
From looking at the most commented and most viewed posts you can tell what was on the mind of palliative care clinicians this past month. In an upcoming post, I will highlight some of the best comments in April.
Top 5 Pallimed Posts for April 2009 (in case you missed them the first time):
FDA Shocks Hospice World: No More RoxanolMost Commented on Posts for April 2009 (in case you don't read the comments):
The Role of Social Networks in FDA Morphine Recall
FDA: Opioids need Risk Evaluation and Mitigation Strategy (REMS)
Lessons Learned Using Twitter at a Medical Conference
?FDA to rescind recall of 20mg/ml morphine solution
FDA Shocks Hospice World: No More Roxanol - 20 commentsAnd don't forget about the Arts & Humanities and Cases blogs. You can access them via subscription (RSS or Email) or clicking on the 'Arts' or 'Cases' images at the top of the blog or your Pallimed newsletter emails. The Arts blog writers have contributed some outstanding and provocative posts recently.
The Role of Social Networks in FDA Morphine Recall - 7 comments
A Painful Pall-Pourri; N/V, Industry; Pain Research Ramblings - 7 comments
?FDA to rescind recall of 20mg/ml morphine solution - 6 comments
Series of Articles on Grieving in Slate - 4 comments